Brief: Lundbeck And Otsuka Announce FDA Acceptance Of SNDA Filing For Brexpiprazole

H Lundbeck A/S

25/06/2024 07:05

June 25 (Reuters) - H Lundbeck A/S  HLUNb.CO :
    * H. LUNDBECK A/S: LUNDBECK AND OTSUKA ANNOUNCE FDA
ACCEPTANCE OF
SNDA FILING FOR BREXPIPRAZOLE IN COMBINATION WITH SERTRALINE FOR
THE TREATMENT OF ADULTS WITH POST-TRAUMATIC STRESS DISORDER
(PTSD)

Source text: https://mfn.se/cis/a/lundbeck/h-lundbeck-a-s-lundbeck-and-otsuka-announce-fda-acceptance-of-snda-filing-for-brexpiprazole-in-combination-with-sertraline-for-the-treatment-of-adults-with-post-traumatic-stress-disorder-ptsd-04865808
Further company coverage:  HLUNb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))